Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 13/20 | 0.75 |
| ▸ | NPC1 | O15118 | 12/20 | 0.75 |
| ▸ | SMN1; SMN2 | Q16637 | 11/20 | 0.75 |
| ▸ | MAPT | P10636 | 10/20 | 0.75 |
| ▸ | TP53 | P04637 | 10/20 | 0.75 |
| ▸ | LMNA | P02545 | 7/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.75 |
| ▸ | MEN1 | O00255 | 5/20 | 0.75 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.75 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.75 |
| ▸ | HPGD | P15428 | 3/20 | 0.75 |
| ▸ | GFER | P55789 | 2/20 | 0.75 |
| ▸ | GAA | P10253 | 2/20 | 0.75 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.75 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.75 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.75 |
| ▸ | CLK1 | P49759 | 1/20 | 0.68 |
| ▸ | NFKB1 | P19838 | 4/20 | 0.67 |
| ▸ | NFKB2 | Q00653 | 4/20 | 0.67 |
| ▸ | RELA | Q04206 | 4/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14631274 | 0.86 | MAPT (0.71) | RAB9ANPC1SMN1; SMN2MAPTTP53 | |
| SCHEMBL14654072 | 0.86 | RAB9A (0.71) | RAB9ANPC1SMN1; SMN2MAPTTP53 | |
| SCHEMBL3109465 | 0.86 | NPC1 (0.77) | RAB9ANPC1SMN1; SMN2MAPTTP53 | |
| SCHEMBL23657583 | 0.86 | MAPT (0.75) | RAB9ANPC1SMN1; SMN2MAPTTP53 | |
| SCHEMBL16562034 | 0.84 | ALDH1A1 (0.79) | RAB9ANPC1SMN1; SMN2MAPTTP53 | |
| SCHEMBL17916670 | 0.82 | NPC1 (0.65) | RAB9ANPC1SMN1; SMN2MAPTTP53 | |
| SCHEMBL17916714 | 0.82 | ALDH1A1 (0.75) | RAB9ANPC1SMN1; SMN2MAPTTP53 | |
| SCHEMBL14631511 | 0.80 | RAB9A (0.62) | RAB9ANPC1SMN1; SMN2MAPTTP53 | |
| SCHEMBL3139724 | 0.77 | MAPT (0.74) | RAB9ANPC1SMN1; SMN2MAPTTP53 | |
| SCHEMBL659214 | 0.76 | TSHR (0.71) | RAB9ANPC1SMN1; SMN2MAPTTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150011528-A1 | PHENYLIMIDE-CONTAINING BENZOTHIAZOLE DERIVATIVE OF ITS SALT AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | YUHAN CORPORATION (KR) | 2015-01-08 | — | — | US | disclosed |
| EP-2758384-A1 | PHENYLIMIDE-CONTAINING BENZOTHIAZOLE DERIVATIVE OR ITS SALT AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | Yuhan Corporation (KR) | 2014-07-30 | — | — | EP | disclosed |
| WO-2013043001-A1 | PHENYLIMIDE-CONTAINING BENZOTHIAZOLE DERIVATIVE OR ITS SALT AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | YUHAN CORPORATION (KR) | 2013-03-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150011528-A1 | PHENYLIMIDE-CONTAINING BENZOTHIAZOLE DERIVATIVE OF ITS SALT AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | ILK, PKMYT1, PLAUR | RAB9A 916/4885NPC1 1984/4885SMN1; SMN2 2126/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.